Evaluation of LYR-220 Mometasone Sinonasal Implants in Patients With Chronic Rhinosinusitis and Prior Ethmoid Surgery: Results From the Randomized, Blinded, Controlled BEACON Phase 2 Study.

Saved in:
Bibliographic Details
Title: Evaluation of LYR-220 Mometasone Sinonasal Implants in Patients With Chronic Rhinosinusitis and Prior Ethmoid Surgery: Results From the Randomized, Blinded, Controlled BEACON Phase 2 Study.
Authors: Senior BA; Department of Otolaryngology, Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Ow RA; Sacramento Ear, Nose, and Throat, Roseville, California, USA., Major MS; Wasatch Ear, Nose, and Throat, Ogden, Utah, USA., Silvers SL; Madison ENT & Facial Plastic Surgery, New York, New York, USA., Rosenbloom JS; Alamo ENT Associates, San Antonio, Texas, USA., Luong AU; Department of Otorhinolaryngology, McGovern Medical School, Houston, Texas, USA., Soler ZM; Department of Otolaryngology, Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA., Naclerio R; Department of Otolaryngology, Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Kern RC; Department of Otolaryngology, Head and Neck Surgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA., Brayton L; Clinical Affairs Department, Lyra Therapeutics, Inc., Waltham, Massachusetts, USA., Mihova M; Clinical Affairs Department, Lyra Therapeutics, Inc., Waltham, Massachusetts, USA., Sajjadi E; Clinical Affairs Department, Lyra Therapeutics, Inc., Waltham, Massachusetts, USA., Lee M; Clinical Affairs Department, Lyra Therapeutics, Inc., Waltham, Massachusetts, USA., Belanger V; Clinical Affairs Department, Lyra Therapeutics, Inc., Waltham, Massachusetts, USA., Nieman R; Clinical Affairs Department, Lyra Therapeutics, Inc., Waltham, Massachusetts, USA.
Source: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2025 Aug; Vol. 15 (8), pp. 818-827. Date of Electronic Publication: 2025 Mar 18.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Published for ARS-AAOA by Wiley-Blackwell Country of Publication: United States NLM ID: 101550261 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-6984 (Electronic) Linking ISSN: 20426976 NLM ISO Abbreviation: Int Forum Allergy Rhinol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2042-6984
DOI:10.1002/alr.23567